Overview

Evaluation of DEX-IN During Outpatient Procedures

Status:
Completed

Trial end date:
2018-01-18

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the analgesic efficacy of DEX-IN compared with placebo and active control (fentanyl), in subjects undergoing painful outpatient and office based procedures.

Phase:

Phase 2

Details

Lead Sponsor:

Recro Pharma, Inc.

Treatments:

Fentanyl